Collaborative action delivering measurable progress
About
AstraZeneca is a biopharmaceutical company working to deliver life-changing medicines while advancing a sustainable future for people, society, and the planet. Through its global supplier network and Ambition Zero Carbon strategy, AstraZeneca is driving measurable reductions in value-chain emissions to help halve its footprint by 2030 and achieve a science-based net-zero target by 2045.
Industry
Pharmaceuticals
Company size
90k+ employees
Emissions reduction
Scope 3
Number of suppliers
123 supplier facilities reporting on Secaro
Number of countries
25 countries represented on Secaro
Working together to cut supply chain emissions
In 2022, AstraZeneca partnered with Secaro to accelerate progress toward its Scope 3 reduction goals by equipping suppliers with a practical platform to measure, manage, and reduce emissions.
Now in its third year, the partnership has evolved into a global network of 123 facilities across 25 countries. Together, these suppliers are building stronger measurement practices, identifying opportunities for emissions reduction, and implementing actions that drive tangible impact.
Turning collaboration into momentum
Since the partnership began, AstraZeneca has established a steady rhythm of supplier engagement, running two dedicated campaigns each year. These campaigns invite suppliers to report their latest emissions and explore new reduction opportunities through Secaro.
Across five completed campaigns (2023-2024), AstraZeneca achieved an average conversion rate of 56%, with most invited suppliers purchasing a Secaro license and actively participating.
To date, 76 organizations, representing 123 facilities in 25 countries, have chosen AstraZeneca as a customer on the platform.
Regional distribution:
- Europe: 44%
- North America: 30%
- Asia: 23%
- Middle East & Africa: 3%
AstraZeneca cannot deliver emissions reduction targets alone. We want to encourage and support all our suppliers to make progress on those goals that protect our planet and people.
Robert Williams, Director of Sustainable Procurement, AstraZeneca
Building a foundation of reliable data
Establishing consistent, high-quality supplier data has been a key focus of AstraZeneca’s program with Secaro. Through regular campaigns and ongoing platform support, suppliers are now building strong reporting habits that enable year-on-year visibility of emissions performance.
Of the 123 participating facilities:
- 72% have submitted emissions data
- 45% have submitted for two consecutive years
- 20% have reported for three years running
- 22 facilities have uploaded historic data
Turning data into action
AstraZeneca’s Ambition Zero Carbon initiative aims to halve its value-chain footprint by 2030 and achieve net zero by 2045. Suppliers’ actions align with this—focused on renewable energy, efficiency, and improved measurement.
Supplier reduction actions (to date):
- 1,000+ actions logged
- 395 completed
- 307 in progress
- 312 planned
Estimated cumulative impact (supplier-estimated):
- 18,791 tCO₂e (Scope 1)
- 386,005 tCO₂e (Scope 2)
- 537,825 m³ water saved
- 1.67 million kg waste reduced
- $4.5 million USD in financial savings
Top 5 actions
- Installing solar PV systems (35 facilities)
- Purchasing renewable energy (23)
- Replacing inefficient lighting with LED (22)
- Calculating facility carbon footprint (18)
- Compressed air leak detection & repairs (18)
Action progress by year:
- 2022: 103 completed
- 2023: 119 completed
- 2024: 93 completed
- 2025 (YTD): 25 completed (+7 scheduled)
46 additional actions logged as historic (pre-partnership).
The impact so far and what’s next
After two full years of campaigns, AstraZeneca and its suppliers have achieved measurable progress:
Participation from 25 countries
A growing base of reliable annual submissions
- 1,000+ reduction actions logged
- 400,000+ tCO₂e savings
- $4.5M in efficiency gains
Next steps include expanding supplier participation and deepening Scope 3 impact through continued campaigns and collaboration with Secaro.